Treatment of Parkinson’s Disease with Phenolic Antioxidant Drugs: Oxidative Stress, Reactive Oxygen Species and Selectivity.

Chronicles of Pharmaceutical Science

Wil Weston¹  Peter Kovacic*² 

[1] Wil Weston, Library and Information Access, San Diego State University, San Diego, CA, USA;Peter Kovacic, Department of Chemistry and Biochemistry, San Diego State University, San Diego, CA, USA

关键词: Parkinson’s disease;    Phenolic antioxidants;    Oxidative stress;   

DOI  :  

学科分类：医学（综合）

来源: Scientia Ricerca

【 摘 要 】

Parkinson’s is one of the most prevalent brain diseases characterized by the presence of oxidative stress and reactive oxygen species. It is also classified as a type of dementia. Phenolic compounds comprise one of the class of drugs for this disease. However, there is no cure available; the drugs act as antioxidants which alleviate the toxic effects. The drugs involved are the following: L-dopa, opicapone, apomorphine, catechin, entacapone, rotigotine, safinamide, and piperine.

【 授权许可】

CC BY